Health Canada may approve favipiravir to treat COVID-19
Health Canada is reviewing an antiviral drug favipiravir, which was developed to treat influenza patients and has shown some evidence it can help treat mild to moderate COVID-19 cases. The drug acts similarly to remdesivir, another antiviral approved to treat COVID-19 patients in Canada. Beyond remdesivir, the only other drug approved is banlamivinab, a monoclonal antibody medication.
Published: December 21, 2020